Perrigo Co. PLC | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,537
4,063
5,268
5,279
4,945
4,731
Cost of Goods Sold (COGS) incl. D&A
2,255
2,607
3,109
3,232
2,973
2,902
Gross Income
1,282
1,457
2,160
2,048
1,971
1,829
SG&A Expense
574
704
1,538
1,392
1,302
1,344
EBIT
708
753
-
656
670
485
Unusual Expense
23
361
391
5,296
227
238
Non Operating Income/Expense
11
26
37
2
5
161
Interest Expense
70
96
176
210
158
120
Pretax Income
608
273
18
4,848
280
291
Income Tax
166
67
67
836
161
160
Consolidated Net Income
442
205
85
4,013
120
131
Net Income
442
205
85
4,013
120
131
Net Income After Extraordinaries
442
205
85
4,013
120
131
Net Income Available to Common
442
205
85
4,013
120
131
EPS (Basic)
4.68
1.77
0.58
28.00
0.84
0.95
Basic Shares Outstanding
94
115
146
143
142
138
EPS (Diluted)
4.68
1.78
0.58
28.00
0.84
0.95
Diluted Shares Outstanding
95
116
146
143
143
138
EBITDA
868
1,112
987
1,113
1,115
908
Non-Operating Interest Income
4
2
-
-
-
-
Equity in Affiliates (Pretax)
-
-
-
-
-
3

About Perrigo Co.

View Profile
Address
The Sharp Building
Dublin Dublin 2
Ireland
Employees -
Website http://www.perrigo.com
Updated 07/08/2019
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals. The Consumer Healthcare Americas segment comprises the U.